Protein kinase Cα downregulation via siRNA-PKCα released from foldable capsular vitreous body in cultured human retinal pigment epithelium cells

References

• SunalpMAWiedemannPSorgenteNRyanSJEffect of adriamycin on experimental proliferative vitreoretinopathy in the rabbitExp Eye Res19854111051154029281
   PubMed Web of Science ®Google Scholar
• CowleyMConwayBPCampochiaroPAKaiserDGaskinHClinical risk factors for proliferative vitreoretinopathyArch Ophthalmol19891078114711512757544
   PubMed Web of Science ®Google Scholar
• KirchhofBStrategies to influence PVR developmentGraefes Arch Clin Exp Ophthalmol2004242869970315309556
   PubMed Web of Science ®Google Scholar
• CardilloJAStoutJTLaBreeLPost-traumatic proliferative vitreoretinopathy. The epidemiologic profile, onset, risk factors, and visual outcomeOphthalmology19971047116611739224471
   PubMed Web of Science ®Google Scholar
• MurphyTLSakamotoTHintonDRMigration of retinal pigment epithelium cells in vitro is regulated by protein kinase CExp Eye Res19956066836957641851
   PubMed Web of Science ®Google Scholar
• HarrisMSSakamotoTKimuraHHypericin inhibits cell growth and induces apoptosis in retinal pigment epithelial cells: possible involvement of protein kinase CCurr Eye Res19961532552628654105
   PubMed Web of Science ®Google Scholar
• SheuSJSakamotoTOsuskyRTransforming growth factor-beta regulates human retinal pigment epithelial cell phagocytosis by influencing a protein kinase C-dependent pathwayGraefes Arch Clin Exp Ophthalmol1994232116957017531168
   PubMed Web of Science ®Google Scholar
• SakamotoTHintonDRSakamotoHCollagen gel contraction induced by retinal pigment epithelial cells and choroidal fibroblasts involves the protein kinase C pathwayCurr Eye Res19941364514597924409
   PubMed Web of Science ®Google Scholar
• NishizukaYThe molecular heterogeneity of protein kinase C and its implications for cellular regulationNature198833461846616653045562
   PubMed Web of Science ®Google Scholar
• MoriartyPDicksonAJErichsenJTBoultonMProtein kinase C isoenzyme expression in retinal cellsOphthalmic Res2000322–3576010754435
   PubMed Web of Science ®Google Scholar
• EvansVGMultiple pathways to apoptosisCell Biol Int19931754614768339064
   PubMed Web of Science ®Google Scholar
• KizakiHSuzukiKTadakumaTIshimuraYAdenosine receptor-mediated accumulation of cyclic AMP-induced T-lymphocyte death through internucleosomal DNA cleavageJ Biol Chem19902659528052841690738
   PubMed Web of Science ®Google Scholar
• YuKMaPGeJExpression of protein kinase C isoforms in cultured human retinal pigment epithelial cellsGraefes Arch Clin Exp Ophthalmol2007245799399917124607
   PubMed Web of Science ®Google Scholar
• GaoQTanJMaPPKC alpha affects cell cycle progression and proliferation in human RPE cells through the downregulation of p27kip1Mol Vis2009152683269520011080
   PubMed Web of Science ®Google Scholar
• HughesPMOlejnikOChang-LinJEWilsonCGTopical and systemic drug delivery to the posterior segmentsAdv Drug Deliv Rev200557142010203216289435
   PubMed Web of Science ®Google Scholar
• Cunha-VazJGThe blood-ocular barriers: past, present, and futureDoc Ophthalmol1997931–21491579476613
   PubMed Web of Science ®Google Scholar
• YasukawaTOguraYTabataYKimuraHWiedemannPHondaYDrug delivery systems for vitreoretinal diseasesProg Retin Eye Res200423325328115177203
   PubMed Web of Science ®Google Scholar
• LiuYKeQChenJSustained mechanical release of dexamethasone sodium phosphate from a foldable capsular vitreous bodyInvest Ophthalmol Vis Sci20105131636164219834025
   PubMed Web of Science ®Google Scholar
• LiuYJiangZGaoQTechnical standards of a foldable capsular vitreous body in terms of mechanical, optical, and biocompatible propertiesArtif Organs2010341083684520618225
   PubMed Web of Science ®Google Scholar
• LinXGeJGaoQEvaluation of the flexibility, efficacy, and safety of a foldable capsular vitreous body in the treatment of severe retinal detachmentInvest Ophthalmol Vis Sci201152137438120811065
   PubMed Web of Science ®Google Scholar
• GaoQMouSGeJA new strategy to replace the natural vitreous by a novel capsular artificial vitreous body with pressure-control valveEye (Lond)200822346146817525767
   PubMed Web of Science ®Google Scholar
• BernsteinECaudyAAHammondSMHannonGJRole for a bidentate ribonuclease in the initiation step of RNA interferenceNature2001409681836336611201747
   PubMed Web of Science ®Google Scholar
• NovinaCDSharpPAThe RNAi revolutionNature2004430699616116415241403
   PubMed Web of Science ®Google Scholar
• ReichSJFosnotJKurokiASmall interfering RNA (siRNA) targeting VEGF effectively inhibits ocular neovascularization in a mouse modelMol Vis2003921021612789138
   PubMed Web of Science ®Google Scholar
• NakamuraHSiddiquiSSShenXRNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosisMol Vis20041070371115475878
   PubMed Web of Science ®Google Scholar
• CinatlJJrMichaelisMFleckensteinCWest Nile virus infection induces interferon signaling in human retinal pigment epithelial cellsInvest Ophthalmol Vis Sci200647264565116431963
   PubMed Web of Science ®Google Scholar
• CampaMJWangMZHowardBFitzgeraldMCPatzEFJrProtein expression profiling identifies macrophage migration inhibitory factor and cyclophilin a as potential molecular targets in non-small cell lung cancerCancer Res20036371652165612670919
   PubMed Web of Science ®Google Scholar
• WeaverSASchaeferALDixonWTWestern blotting for detection of glucocorticoid receptors in the brain and pituitary gland from adrenal intact pigsBrain Res20008691–213013610865067
   PubMed Web of Science ®Google Scholar
• AcharyaGShinCSVedanthamKA study of drug release from homogeneous PLGA microstructuresJ Control Release2010146220120620381555
   PubMed Web of Science ®Google Scholar
• ColthurstMJWilliamsRLHiscottPSGriersonIBiomaterials used in the posterior segment of the eyeBiomaterials200021764966510711963
   PubMed Web of Science ®Google Scholar
• GaoQChenXGeJRefractive shifts in four selected artificial vitreous substitutes based on Gullstrand-Emsley and Liou-Brennan schematic eyesInvest Ophthalmol Vis Sci20095073529353419264881
   PubMed Web of Science ®Google Scholar
• ChenJGaoQLiuYClinical device-related article evaluation of morphology and functions of a foldable capsular vitreous body in the rabbit eyeJ Biomed Mater Res B Appl Biomater201197239640421442743
   PubMed Web of Science ®Google Scholar
• FattalEBarrattGNanotechnologies and controlled release systems for the delivery of antisense oligonucleotides and small interfering RNABr J Pharmacol2009157217919419366348
   PubMed Web of Science ®Google Scholar
• Andrieu-SolerCBejjaniRAde BizemontTNormandNBenEzraDBehar-CohenFOcular gene therapy: a review of nonviral strategiesMol Vis2006121334134717110916
   PubMed Web of Science ®Google Scholar
• KleinmanMEYamadaKTakedaASequence- and target-independent angiogenesis suppression by siRNA via TLR3Nature2008452718759159718368052
   PubMed Web of Science ®Google Scholar
• ChoWGAlbuquerqueRJKleinmanMESmall interfering RNA-induced TLR3 activation inhibits blood and lymphatic vessel growthProc Natl Acad Sci U S A2009106177137714219359485
   PubMed Web of Science ®Google Scholar
• ChengLHostetlerKValiaevaNIntravitreal crystalline drug delivery for intraocular proliferation diseasesInvest Ophthalmol Vis Sci201051147448119696179
   PubMed Web of Science ®Google Scholar
• GuidettiBAzémaJMalet-MartinoMMartinoRDelivery systems for the treatment of proliferative vitreoretinopathy: materials, devices and colloidal carriersCurr Drug Deliv20085171918220546
   PubMedGoogle Scholar